These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16489056)

  • 1. A prospective study of serum C-reactive protein and colorectal cancer risk in men.
    Gunter MJ; Stolzenberg-Solomon R; Cross AJ; Leitzmann MF; Weinstein S; Wood RJ; Virtamo J; Taylor PR; Albanes D; Sinha R
    Cancer Res; 2006 Feb; 66(4):2483-7. PubMed ID: 16489056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
    Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein concentrations and subsequent ovarian cancer risk.
    McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
    Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men.
    Chiu HM; Lin JT; Chen TH; Lee YC; Chiu YH; Liang JT; Shun CT; Wu MS
    Am J Gastroenterol; 2008 Sep; 103(9):2317-25. PubMed ID: 18844617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma enterolignan concentrations and colorectal cancer risk in a nested case-control study.
    Kuijsten A; Hollman PC; Boshuizen HC; Buijsman MN; van 't Veer P; Kok FJ; Arts IC; Bueno-de-Mesquita HB
    Am J Epidemiol; 2008 Mar; 167(6):734-42. PubMed ID: 18192676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
    Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
    J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein and colorectal adenoma in the CLUE II cohort.
    Tsilidis KK; Erlinger TP; Rifai N; Hoffman S; Hoffman-Bolton J; Helzlsouer KJ; Platz EA
    Cancer Causes Control; 2008 Aug; 19(6):559-67. PubMed ID: 18214695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum oxidized low-density lipoprotein levels and risk of colorectal cancer: a case-control study nested in the Japan Collaborative Cohort Study.
    Suzuki K; Ito Y; Wakai K; Kawado M; Hashimoto S; Toyoshima H; Kojima M; Tokudome S; Hayakawa N; Watanabe Y; Tamakoshi K; Suzuki S; Ozasa K; Tamakoshi A;
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1781-7. PubMed ID: 15533907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea.
    Chung YW; Han DS; Park YK; Son BK; Paik CH; Lee HL; Jeon YC; Sohn JH
    Dig Liver Dis; 2006 Sep; 38(9):668-72. PubMed ID: 16790371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein levels and subsequent cancer outcomes: results from a prospective cohort study.
    Helzlsouer KJ; Erlinger TP; Platz EA
    Eur J Cancer; 2006 Apr; 42(6):704-7. PubMed ID: 16513341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is C-reactive protein a prognostic factor of colorectal cancer?
    Shiu YC; Lin JK; Huang CJ; Jiang JK; Wang LW; Huang HC; Yang SH
    Dis Colon Rectum; 2008 Apr; 51(4):443-9. PubMed ID: 18172726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study.
    Weinstein SJ; Wright ME; Pietinen P; King I; Tan C; Taylor PR; Virtamo J; Albanes D
    J Natl Cancer Inst; 2005 Mar; 97(5):396-9. PubMed ID: 15741576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and the risk of incident colorectal cancer.
    Erlinger TP; Platz EA; Rifai N; Helzlsouer KJ
    JAMA; 2004 Feb; 291(5):585-90. PubMed ID: 14762037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma folate and risk of colorectal cancer in a nested case-control study: the Japan Public Health Center-based prospective study.
    Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
    Cancer Causes Control; 2008 Feb; 19(1):67-74. PubMed ID: 17943453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of waist circumference and body mass index in relation to colorectal cancer incidence.
    Wang Y; Jacobs EJ; Patel AV; Rodríguez C; McCullough ML; Thun MJ; Calle EE
    Cancer Causes Control; 2008 Sep; 19(7):783-92. PubMed ID: 18322811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary intake of omega-6 and omega-3 fatty acids and risk of colorectal cancer in a prospective cohort of U.S. men and women.
    Daniel CR; McCullough ML; Patel RC; Jacobs EJ; Flanders WD; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):516-25. PubMed ID: 19190143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden.
    Stattin P; Palmqvist R; Söderberg S; Biessy C; Ardnor B; Hallmans G; Kaaks R; Olsson T
    Oncol Rep; 2003; 10(6):2015-21. PubMed ID: 14534736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma C-reactive protein and risk of cancer: a prospective study from Greece.
    Trichopoulos D; Psaltopoulou T; Orfanos P; Trichopoulou A; Boffetta P
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):381-4. PubMed ID: 16492932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer.
    Dymicka-Piekarska V; Matowicka-Karna J; Gryko M; Kemona-Chetnik I; Kemona H
    Thromb Res; 2007; 120(4):585-90. PubMed ID: 17169411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.